Startups

Mission is to use proprietary state-of-the-art SCIslet differentiation technology to make stem cell-derived islets accessible to diabetes researchers

Develops off-the-shelf cellular therapies for cancer

Focused on the rational drug discovery and development of sHAIs as a more effective treatment option for lung and colon cancer patients, including those which are resistant to current therapies

Aims to diagnose autism early using machine learning to identify brain patterns

A privately-owned clinical-stage pharmaceutical company that has established the most comprehensive portfolio of proprietary NAD+ precursors in the world

Develops ErythroMer, a dried, bio-inspired artificial red blood cell, to treat life-threatening blood loss when stored red blood cells are unavailable, undesirable or in short supply

Detecting cancer earlier with foundational epigenetic enrichment technology,

A biotechnology company launched to address lysosomal dysfunction in rare, genetically defined neurodegenerative diseases

A precision medicine company personalizing the drug development process by introducing patient-derived and gene-edited human samples, including 3D engineered microtissues

A startup with the potential to revolutionize cancer treatment and is committed to improving outcomes for all patients